Health systems analysis and evaluation of the barriers to availability, utilisation and readiness of sexual and reproductive health services in COVID-19-affected areas: a WHO mixed-methods study protocol
- PMID: 35649598
- PMCID: PMC9160592
- DOI: 10.1136/bmjopen-2021-057810
Health systems analysis and evaluation of the barriers to availability, utilisation and readiness of sexual and reproductive health services in COVID-19-affected areas: a WHO mixed-methods study protocol
Abstract
Introduction: COVID-19 has led to an unprecedented increase in demand on health systems to care for people infected, necessitating the allocation of significant resources, especially medical resources, towards the response. This, compounded by the restrictions on movement instituted may have led to disruptions in the provision of essential services, including sexual and reproductive health (SRH) services. This study aims to assess the availability of contraception, comprehensive abortion care, sexually transmitted infection prevention and treatment and sexual and gender-based violence care and support services in local health facilities during COVID-19 pandemic. This is a standardised generic protocol designed for use across different global settings.
Methods and analysis: This study adopts both quantitative and qualitative methods to assess health facilities' SRH service availability and readiness, and clients' and providers' perceptions of the availability and readiness of these services in COVID-19-affected areas. The study has two levels: (1) perceptions of clients (and the partners) and healthcare providers, using qualitative methods, and (2) assessment of infrastructure availability and readiness to provide SRH services through reviews, facility service statistics for clients and a qualitative survey for healthcare provider perspectives. The health system assessment will use a cross-sectional panel survey design with two data collection points to capture changes in SRH services availability as a result of the COVID-19 epidemic. Data will be collected using focus group discussions, in-depth interviews and a health facility assessment survey.
Ethics and dissemination: Ethical approval for this study was obtained from the WHO Scientific and Ethics Review Committee (protocol ID CERC.0103). Each study site is required to obtain the necessary ethical and regulatory approvals that are required in each specific country.
Keywords: COVID-19; public health; reproductive medicine.
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
References
-
- Addressing human rights as key to the COVID-19 response. Geneva: World Health Organization; (WHO/2019-nCoV/SRH/Rights/2020), 2020. Available: https://www.who.int/publications/i/item/addressing-human-rights-as-key-t... [Accessed 15 Aug 2020].
-
- Sexual and reproductive health and rights during the COVID-19 pandemic: a joint report by EPF & IPPF EN, 2020. Available: https://www.ippfen.org/sites/ippfen/files/2020-04/SexualandReproductiveH... [Accessed 16 Aug 2020].
-
- COVID-19: operational guidance for maintaining essential health services during an outbreak: interim guidance.Geneva: World Health Organization. 2020 WHO/2019-nCoV/essential_health_services/2020, 2020. Available: https://apps.who.int/iris/handle/10665/331561 [Accessed 15 Aug 2020].
-
- World Health Organisation . Maintaining essential health services: operational guidance for the COVID-19 context, 2020. Available: https://apps.who.int/iris/handle/10665/332240 [Accessed 15 Aug 2020].
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical